Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 513 | 0.91 |
| pathways Reactome | 5 pathways; mostly protein handling | 0.90 |
No case: the score is under the bar. Receipt 11110
Sealed predictions
- CUL2 in dopamine neurons, braak+0.27 (p 0.485) → +0.45 (p 0.219)receipt 11117
Swarm cases
receipt 11117: CUL2 in dopamine neurons, braak
- power
- full sample +0.38 (p 0.118, n 18), 95% CI -0.10 to +0.72. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.49 (p 0.037, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.49 (p 0.037, n 18). not the mix.
- skeptic
- leave-one-out range +0.31 to +0.48, sign flips 0; without severely affected donors +0.38 (p 0.118, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CUL2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts